{
    "symbol": "ISPC",
    "quarter": 3,
    "year": 2022,
    "date": "2022-11-08 19:10:26",
    "content": "  For the three months ended September 30, 2022 and 2021, revenue derived from non-COVID-19 related specimens accounted for approximately $2.3 million and $1.8 million or 88% and 66%, respectively, of our total revenue, a 26% increase in non-COVID-19 revenue compared to the same prior year's period and an all-time record-breaking high of non-COVID-19 revenue for the company. For the nine months ended September 30, 2022 and 2021, revenue derived from non-COVID-19 related specimens accounted for approximately $6.5 million and $6.1 million or 87% and 71%, respectively, of our total revenue, a 7% increase in non-COVID-19 revenue compared to the same prior year's period."
}